Alternative Antibiotics for Central Line Infections

Introduction to Alternative Antibiotics

The American Heart Association recommends daptomycin as a reasonable alternative to vancomycin for treatment of Staphylococcus aureus bloodstream infections and endocarditis in patients with allergies to both vancomycin and penicillin 1, 2
For central line infections, the recommended dose of daptomycin is 6 mg/kg IV once daily, though some experts recommend higher doses of 8-10 mg/kg for complicated infections 2, 3

Daptomycin has demonstrated efficacy in clinical trials, and infectious disease consultation is recommended for selection of appropriate daptomycin dosing (Class I; Level of Evidence C) 3

Linezolid 600 mg PO/IV every 12 hours is an alternative option for patients with allergies to both vancomycin and penicillin, particularly useful for methicillin-resistant Staphylococcus aureus (MRSA) infections when daptomycin cannot be used 4, 5
Cotrimoxazole (Sulfamethoxazole-Trimethoprim) is an alternative option for Staphylococcus aureus infections, with a recommended dose of Sulfamethoxazole 4800 mg/day and Trimethoprim 960 mg/day (IV in 4-6 doses) for 1 week IV followed by 5 weeks oral therapy 6, 7

Daptomycin is preferred for both methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) staphylococcal infections, and has been shown to clear MRSA bacteremia faster than standard-of-care treatment in observational studies 2, 5
For enterococcal infections, daptomycin 6 mg/kg IV q24h is recommended for penicillin-resistant enterococcal infections in penicillin-allergic patients 4, 5

Monitor CPK (creatine phosphokinase) levels at least weekly with daptomycin therapy due to risk of myopathy 5
Daptomycin is contraindicated for pneumonia treatment due to inactivation by pulmonary surfactant, but remains effective for septic pulmonary emboli from bloodstream infections 3

For uncomplicated central line infections, 4 weeks of therapy is typically recommended 4
For complicated infections (e.g., with endocarditis or metastatic foci), 6 weeks of therapy is recommended 6, 4

Avoid clindamycin as monotherapy for serious bloodstream infections as it has been associated with endocarditis relapse 2
Do not use daptomycin for primary pneumonia treatment due to inactivation by pulmonary surfactant 3
Consider the possibility of desensitization protocols for penicillin allergy in stable patients if other options are limited 2